139 related articles for article (PubMed ID: 25579547)
1. Changes of serum albumin level and systemic inflammatory response in inoperable non-small cell lung cancer patients after chemotherapy.
Wang X; Han H; Duan Q; Khan U; Hu Y; Yao X
J Cancer Res Ther; 2014; 10(4):1019-23. PubMed ID: 25579547
[TBL] [Abstract][Full Text] [Related]
2. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study.
Arrieta O; Michel Ortega RM; Villanueva-Rodríguez G; Serna-Thomé MG; Flores-Estrada D; Diaz-Romero C; Rodríguez CM; Martínez L; Sánchez-Lara K
BMC Cancer; 2010 Feb; 10():50. PubMed ID: 20170547
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer.
Yildirim M; Yildiz M; Duman E; Goktas S; Kaya V
J BUON; 2013; 18(3):728-32. PubMed ID: 24065491
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
Ikeda S; Yoshioka H; Ikeo S; Morita M; Sone N; Niwa T; Nishiyama A; Yokoyama T; Sekine A; Ogura T; Ishida T
BMC Cancer; 2017 Nov; 17(1):797. PubMed ID: 29183294
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
6. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
[TBL] [Abstract][Full Text] [Related]
8. Impact of Age on Inflammation-Based Scores among Patients Diagnosed with Stage III Non-Small Cell Lung Cancer.
Palomar-Abril V; Soria-Comes T; Tarazona Campos S; Martín Ureste M; Giner Bosch V; Maestu Maiques IC
Oncology; 2020; 98(8):528-533. PubMed ID: 32203963
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein as a monitor of chemotherapy response in advanced non-small cell lung cancer (CML study).
Srimuninnimit V; Ariyapanya S; Nimmannit A; Wonglaksanapimon S; Akewanlop C; Soparattanapaisarn N
J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S199-207. PubMed ID: 22574550
[TBL] [Abstract][Full Text] [Related]
10. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
Lee JG; Cho BC; Bae MK; Lee CY; Park IK; Kim DJ; Ahn SV; Chung KY
Lung Cancer; 2009 Jan; 63(1):106-10. PubMed ID: 18513823
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.
Koh YW; Lee HW
Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774
[TBL] [Abstract][Full Text] [Related]
12. Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
Sun H; Hu P; Shen H; Dong W; Zhang T; Liu Q; Du J
PLoS One; 2015; 10(12):e0144663. PubMed ID: 26656866
[TBL] [Abstract][Full Text] [Related]
13. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer.
Meek CL; Wallace AM; Forrest LM; McMillan DC
Clin Nutr; 2010 Apr; 29(2):206-9. PubMed ID: 19748165
[TBL] [Abstract][Full Text] [Related]
16. [The incidence of sick euthyroid syndrome in non-small cell lung cancer patients].
Seyhan EC; Cetinkaya E; Altin S; Gençoğlu A; Simşek N
Tuberk Toraks; 2008; 56(2):163-70. PubMed ID: 18701976
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
[TBL] [Abstract][Full Text] [Related]
18. Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer.
Wilop S; Crysandt M; Bendel M; Mahnken AH; Osieka R; Jost E
Onkologie; 2008 Dec; 31(12):665-70. PubMed ID: 19060504
[TBL] [Abstract][Full Text] [Related]
19. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
20. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.
Vollmer RT; Govindan R; Graziano SL; Gamble G; Garst J; Kelley MJ; Christenson RH
Clin Cancer Res; 2003 May; 9(5):1728-33. PubMed ID: 12738727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]